Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • rashmijain
    Junior Member
    • Feb 2014
    • 7

    #1

    pindel analysis

    Hi

    I am working on PINDEL file, I am not sure what should be the criteria to filter pindel fie so that most of the false positives are removed.
    what should be the value for AD/DP to get significant result?

    Any help appreciated.

    Thank you
  • KaiYe
    Senior Member
    • Jun 2009
    • 133

    #2
    Originally posted by rashmijain View Post
    Hi

    I am working on PINDEL file, I am not sure what should be the criteria to filter pindel fie so that most of the false positives are removed.
    what should be the value for AD/DP to get significant result?

    Any help appreciated.

    Thank you
    you could use the number of reads supporting the ALT for filtering. If you have multiple samples, if one variant appears in multple samples, it is more likely to e true. you could also use variant allele frequency for filtering as well.

    Comment

    • rashmijain
      Junior Member
      • Feb 2014
      • 7

      #3
      Thank you for the reply.
      I have data in this format

      Chr1 1000 . . PASS AC=5,1;AN=6;END=1073;HOMLEN=0;NTLEN=3;SF=1,2,11,19,36,43;SVLEN=73;SVTYPE=DUP:TANDEM GTP:AD . 1/.:27:3 2/.:16:4
      Chr1 1002 . . PASS AC=3;AN=3;END=1064;HOMLEN=0;NTLEN=0;SF=0,13,29;SVLEN=62;SVTYPE=DUP:TANDEM GTP:AD 1/.:88:3 . .
      Chr1 1064 . . PASS AC=10,22,2;AN=34;END=1064;HOMLEN=9;HOMSEQ=AAACCCTAA;SF=0,1,2,3,7,9,10,11,12,13,15,16,17,18,19,22,24,25,26,28,29,31,32,33,37,38,39,40,41,42,43,44,45,46;SVLEN=14;SVTYPE=INS GTP:AD 1/.:459:3 1/.:494:4 2/.:503:8
      Chr1 1064 . . PASS AC=10;AN=10;END=1064;HOMLEN=9;HOMSEQ=AAACCCTAA;SF=0,1,9,13,16,28,29,31,42,45;SVLEN=34;SVTYPE=INS GTP:AD 1/.:459:6 1/.:494:11 .
      Chr1 1090 . . PASS AC=17,1;AN=18;END=1090;HOMLEN=10;HOMSEQ=TAAACCCTAA;SF=0,1,2,3,5,6,10,12,16,19,22,23,24,33,36,43,44,46;SVLEN=27;SVTYPE=INS GTP:AD 1/.:478:4 1/.:511:3 1/.:532:3
      Chr1 1090 . . PASS AC=1;AN=1;END=1090;HOMLEN=3;HOMSEQ=TAA;SF=0;SVLEN=47;SVTYPE=INS GTP:AD 1/.:478:4 . .
      Chr1 20836 . . PASS AC=47;AN=47;END=20837;HOMLEN=9;HOMSEQ=AAAAAAAAA;SF=0,1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46;SVLEN=-1;SVTYPE=DEL GTP:AD 1/.:97:62 1/.:104:72 1/.:95:74
      Chr1 23314 . . PASS AC=47;AN=47;END=23318;HOMLEN=56;HOMSEQ=TATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATCTATC;SF=0,1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46;SVLEN=-4;SVTYPE=DEL GTP:AD 1/.:78:15 1/.:72:15 1/.:78:18

      I don't find any column with allele frequency. Do I need to calculate this myself?
      Should I select only GT 1/. and AD/DP=?

      I am new to do NGS analysis. I have tried to understand AD and DP by reading manual, but still not able to understand. It would be helpful if anybody can give me simple explanation for this.

      Thank you

      Rashmi

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      33 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      41 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Working...